5k26 - Revision history

OCA at 19:18, 20 September 2023

OCA — Wed, 20 Sep 2023 19:18:52 GMT

←Older revision		Revision as of 19:18, 20 September 2023
Line 1:		Line 1:

	==Structure of the SH3 domain of MLK3 bound to peptide generated from phage display==		==Structure of the SH3 domain of MLK3 bound to peptide generated from phage display==
-	<StructureSection load='5k26' size='340' side='right' caption='[[5k26]], [[Resolution\|resolution]] 1.20Å' scene=''>	+	<StructureSection load='5k26' size='340' side='right'caption='[[5k26]], [[Resolution\|resolution]] 1.20Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5k26]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5K26 OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5K26 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5k26]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5K26 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5K26 FirstGlance]. <br>
-	</td></tr><tr id='~~ligand~~'><td class="sblockLbl"><b>[[~~Ligand~~\|~~Ligands~~:]]</b></td><td class="sblockDat"~~><scene name='pdbligand=MES:2-(N-MORPHOLINO)-ETHANESULFONIC+ACID'>MES</scene></td></tr>~~	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.2Å</td></tr>
-	~~<tr~~ id~~='related'><td class~~="~~sblockLbl~~">~~<b>~~[[~~Related_structure~~\|~~Related:]]</b></td><td class="sblockDat">[[5k28\|5k28~~]]</td></tr>	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=MES:2-(N-MORPHOLINO)-ETHANESULFONIC+ACID'>MES</scene></td></tr>
-	<tr id='~~gene~~'><td class="sblockLbl"><b>[[~~Gene~~\|~~Gene~~:]]</b></td><td class="sblockDat">~~MAP3K11, MLK3, PTK1, SPRK ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode~~=~~Info&srchmode~~=~~5&id=9606 HUMAN]~~)</td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5k26 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5k26 OCA], [https://pdbe.org/5k26 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5k26 RCSB], [https://www.ebi.ac.uk/pdbsum/5k26 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5k26 ProSAT]</span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5k26 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5k26 OCA], [~~http~~://pdbe.org/5k26 PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=5k26 RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/5k26 PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=5k26 ProSAT]</span></td></tr>	+
	</table>		</table>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/M3K11_HUMAN M3K11_HUMAN]] Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle.<ref>PMID:12529434</ref> <ref>PMID:15258589</ref> <ref>PMID:8195146</ref> <ref>PMID:9003778</ref>	+	[https://www.uniprot.org/uniprot/M3K11_HUMAN M3K11_HUMAN] Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle.<ref>PMID:12529434</ref> <ref>PMID:15258589</ref> <ref>PMID:8195146</ref> <ref>PMID:9003778</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 24:		Line 23:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
-	[[Category: ~~Kall, S K~~]]	+	[[Category: Large Structures]]
-	[[Category: ~~Lavie, A~~]]	+	[[Category: Kall SK]]
-	[[Category: ~~Mlk3]]~~	+	[[Category: Lavie A]]
-	~~[[Category: Phage display]]~~	+
-	~~[[Category: Sh3]]~~	+
-	~~[[Category: Signalling protein]]~~	+
-	~~[[Category: Transferase~~]]	+

OCA at 08:28, 26 December 2018

OCA — Wed, 26 Dec 2018 08:28:40 GMT

←Older revision		Revision as of 08:28, 26 December 2018
Line 3:		Line 3:
	<StructureSection load='5k26' size='340' side='right' caption='[[5k26]], [[Resolution\|resolution]] 1.20Å' scene=''>		<StructureSection load='5k26' size='340' side='right' caption='[[5k26]], [[Resolution\|resolution]] 1.20Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5k26]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5K26 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5K26 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5k26]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5K26 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5K26 FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MES:2-(N-MORPHOLINO)-ETHANESULFONIC+ACID'>MES</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MES:2-(N-MORPHOLINO)-ETHANESULFONIC+ACID'>MES</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5k28\|5k28]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5k28\|5k28]]</td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">MAP3K11, MLK3, PTK1, SPRK ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5k26 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5k26 OCA], [http://pdbe.org/5k26 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5k26 RCSB], [http://www.ebi.ac.uk/pdbsum/5k26 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5k26 ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5k26 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5k26 OCA], [http://pdbe.org/5k26 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5k26 RCSB], [http://www.ebi.ac.uk/pdbsum/5k26 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5k26 ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/M3K11_HUMAN M3K11_HUMAN]] Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle.<ref>PMID:12529434</ref> <ref>PMID:15258589</ref> <ref>PMID:8195146</ref> <ref>PMID:9003778</ref>		[[http://www.uniprot.org/uniprot/M3K11_HUMAN M3K11_HUMAN]] Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle.<ref>PMID:12529434</ref> <ref>PMID:15258589</ref> <ref>PMID:8195146</ref> <ref>PMID:9003778</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Mixed-lineage kinase 3 (MLK3; also known as MAP3K11) is a Ser/Thr protein kinase widely expressed in normal and cancerous tissues, including brain, lung, liver, heart, and skeletal muscle tissues. Its Src homology 3 (SH3) domain has been implicated in MLK3 autoinhibition and interactions with other proteins, including those from viruses. The MLK3 SH3 domain contains a six-amino-acid insert corresponding to the n-Src insert, suggesting that MLK3 may bind additional peptides. Here, affinity selection of a phage-displayed combinatorial peptide library for MLK3's SH3 domain yielded a 13-mer peptide, designated "MLK3 SH3-interacting peptide" (MIP). Unlike most SH3 domain peptide ligands, MIP contained a single proline. The 1.2-A crystal structure of the MIP-bound SH3 domain revealed that the peptide adopts a beta-hairpin shape, and comparison with a 1.5-A apo SH3 domain structure disclosed that the n-Src loop in SH3 undergoes an MIP-induced conformational change. A 1.5-A structure of the MLK3 SH3 domain bound to a canonical proline-rich peptide from hepatitis C virus nonstructural 5A (NS5A) protein revealed that it and MIP bind the SH3 domain at two distinct sites, but biophysical analyses suggested that the two peptides compete with each other for SH3 binding. Moreover, SH3 domains of MLK1 and MLK4, but not MLK2, also bound MIP, suggesting that the MLK1-4 family may be differentially regulated through their SH3 domains. In summary, we have identified two distinct peptide-binding sites in the SH3 domain of MLK3, providing critical insights into mechanisms of ligand binding by the MLK family of kinases.
		+
		+	Identification of two distinct peptide-binding pockets in the SH3 domain of human mixed-lineage kinase 3.,Kokoszka ME, Kall SL, Khosla S, McGinnis JE, Lavie A, Kay BK J Biol Chem. 2018 Aug 31;293(35):13553-13565. doi: 10.1074/jbc.RA117.000262. Epub, 2018 Jul 6. PMID:29980598<ref>PMID:29980598</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 5k26" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
	[[Category: Kall, S K]]		[[Category: Kall, S K]]
	[[Category: Lavie, A]]		[[Category: Lavie, A]]

OCA at 06:53, 13 December 2017

OCA — Wed, 13 Dec 2017 06:53:28 GMT

←Older revision		Revision as of 06:53, 13 December 2017
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry 5k26 is ON HOLD until Dec 13 2018~~	+	==Structure of the SH3 domain of MLK3 bound to peptide generated from phage display==
-		+	<StructureSection load='5k26' size='340' side='right' caption='[[5k26]], [[Resolution\|resolution]] 1.20Å' scene=''>
-	~~Authors: Kall, S.K., Lavie, A.~~	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[5k26]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5K26 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5K26 FirstGlance]. <br>
-	~~Description:~~ Structure of the SH3 domain of MLK3 bound to peptide generated from phage display	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MES:2-(N-MORPHOLINO)-ETHANESULFONIC+ACID'>MES</scene></td></tr>
-	[[~~Category~~: ~~Unreleased Structures~~]]	+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5k28\|5k28]]</td></tr>
-	[[Category: Kall, S.K]]	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5k26 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5k26 OCA], [http://pdbe.org/5k26 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5k26 RCSB], [http://www.ebi.ac.uk/pdbsum/5k26 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5k26 ProSAT]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/M3K11_HUMAN M3K11_HUMAN]] Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle.<ref>PMID:12529434</ref> <ref>PMID:15258589</ref> <ref>PMID:8195146</ref> <ref>PMID:9003778</ref>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Kall, S K]]
	[[Category: Lavie, A]]		[[Category: Lavie, A]]
		+	[[Category: Mlk3]]
		+	[[Category: Phage display]]
		+	[[Category: Sh3]]
		+	[[Category: Signalling protein]]
		+	[[Category: Transferase]]

OCA at 06:21, 8 November 2017

OCA — Wed, 08 Nov 2017 06:21:09 GMT

←Older revision		Revision as of 06:21, 8 November 2017
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 5k26 is ON HOLD until ~~Nov 22~~ 2018	+	The entry 5k26 is ON HOLD until Dec 13 2018

	Authors: Kall, S.K., Lavie, A.		Authors: Kall, S.K., Lavie, A.

OCA at 10:06, 17 May 2017

OCA — Wed, 17 May 2017 10:06:22 GMT

←Older revision		Revision as of 10:06, 17 May 2017
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 5k26 is ON HOLD until ~~Paper Publication~~	+	The entry 5k26 is ON HOLD until Nov 22 2018

	Authors: Kall, S.K., Lavie, A.		Authors: Kall, S.K., Lavie, A.

OCA at 12:36, 27 July 2016

OCA — Wed, 27 Jul 2016 12:36:30 GMT

←Older revision		Revision as of 12:36, 27 July 2016
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 5k26 is ON HOLD	+	The entry 5k26 is ON HOLD until Paper Publication

	Authors: Kall, S.K., Lavie, A.		Authors: Kall, S.K., Lavie, A.

OCA: Protected "5k26" [edit=sysop:move=sysop]

OCA — Wed, 01 Jun 2016 14:12:49 GMT

Protected "5k26" [edit=sysop:move=sysop]

←Older revision

Revision as of 14:12, 1 June 2016

OCA: New page: '''Unreleased structure''' The entry 5k26 is ON HOLD Authors: Kall, S.K., Lavie, A. Description: Structure of the SH3 domain of MLK3 bound to peptide generated from phage display [[Cat...

OCA — Wed, 01 Jun 2016 14:12:48 GMT

New page: '''Unreleased structure''' The entry 5k26 is ON HOLD Authors: Kall, S.K., Lavie, A. Description: Structure of the SH3 domain of MLK3 bound to peptide generated from phage display [[Cat...

New page

'''Unreleased structure'''

The entry 5k26 is ON HOLD

Authors: Kall, S.K., Lavie, A.

Description: Structure of the SH3 domain of MLK3 bound to peptide generated from phage display
[[Category: Unreleased Structures]]
[[Category: Kall, S.K]]
[[Category: Lavie, A]]